Salah-Eddin Al-Batran, MD, on Gastric Cancer: RADPAC Trial Results

2017 Gastrointestinal Cancers Symposium
Tweet this page

Salah-Eddin Al-Batran, MD, of the Institute of Clinical Cancer Research and Nordwest Hospital, discusses study findings on paclitaxel with and without RAD001 in patients with gastric cancer whose disease has progressed after therapy with a fluoropyrimidine/platinum-containing regimen (Abstract 4).

Advertisement

Advertisement



Advertisement